Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · page 22 of 56
Uses YTE modification as a mechanism for half-life extension.
Pitch deck · competitive_analysis · compare_peers · balanced density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 list 1/1 source-note 1/1 title 1/1
Components 4
bar-horizontal bullet source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.